Jean‐François Chatal

Prognostic Impact of Serum Calcitonin and Carcinoembryonic Antigen Doubling-Times in Patients with Medullary Thyroid Carcinoma

Jacques Barbet, L. Campion, Françoise Kraeber‐Bodéré et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 399 citations

Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group

Jean‐François Chatal, L. Campion, Françoise Kraeber‐Bodéré et al. · Journal of Clinical Oncology · 2006 · 228 citations · Full text

Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement

Françoise Kraeber‐Bodéré, L. Campion, Caroline Rousseau et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 134 citations

Surgical Oncology, Radiation Medicine, Urology +9

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

Chien‐Hsing Chang, Robert M. Sharkey, Edmund A. Rossi et al. · PubMed · 2002 · 129 citations

Engineering, Targeted Delivery, Immunology +18

Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.

Françoise Kraeber‐Bodéré, Caroline Rousseau, Caroline Bodet‐Milin et al. · PubMed · 2006 · 127 citations